Virios Therapeutics Inc (VIRI)

[McMagyar]

There is no immediate fda risk..
Basically they have approved our phase 3.

They would have had to raise money at $160,000,000 million market cap .. so that was priced in to $160,000,000 valuation
Plus we have another drug about to report phase 1 safety / early efficacy signal in June..

And a good short run puts us in place to raise clinical capital cheap..

111,000,000 share trade In one day up to $1.40..

Shareholder meeting Thursday going to be sweet